Innovative Antibiotics to target drugresistant microbes: D_Bug

Last update: Nov 18, 2022 Last update: 18 Nov, 2022

Details

Locations: France

Start Date: Nov 1, 2017

End Date: Apr 30, 2019

Value: € 150 000

Sectors:

Health, Science & Innovation

Categories: Grants

Funding Agencies:

Horizon 2020 (2014 - 2020)

Date posted: Nov 18, 2022

Associated funding

Associated experts

Description

Programme(s): H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)

Topic(s): ERC-2017-PoC - ERC-Proof of Concept

Call for proposal: ERC-2017-PoC

Funding Scheme: ERC-POC - Proof of Concept Grant

Grant agreement ID: 780383

Objective: Antibiotic resistance has become a major public health threat in Europe and the United States where resistant bacteria are directly responsible for ten of thousands deaths per year. The D_Bug project aims to develop innovative antibiotics to target drug-resistant microbes.

Reference — Innovative Antibiotics to target drugresistant microbes: D_Bug — for France presented by Horizon 2020 (2014 - 2020) (grants), budget is € 150 000, in Health, Science & Innovation sectors. Reference — Innovative Antibiotics to target drugresistant microbes: D_Bug — for France presented by Horizon 2020 (2014 - 2020) (grants), budget is € 150 000, in Health, Science & Innovation sectors. Reference — Innovative Antibiotics to target drugresistant microbes: D_Bug — for France presented by Horizon 2020 (2014 - 2020) (grants), budget is € 150 000, in Health, Science & Innovation sectors. Reference — Innovative Antibiotics to target drugr...

Want to unlock full information?

Member-only information. Become a member to access projects awards, find the right consortia partners, subcontractors and more.